Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 October 2019 | Story Ruan Bruwer | Photo Varsity Sports
Lefebere and Khanyisa
Lefébre Rademan (left) and Khanyisa Chawane before the start of the Varsity Netball clash. Rademan was named the Player of the Tournament, a reward Chawane received last year.

For the sixth time in the seven years of the competition, the best player in the Varsity Netball tournament hails from the University of the Free State (UFS).

Lefébre Rademan, captain of the Kovsie netball team who ended third in Varsity Netball, was named as the Player of the Tournament and the Players’ Player of the Tournament on Monday night (7 October). Previous UFS recipients of the award are Ané Bester (2013), Karla Pretorius (in 2014 and 2015), Khomotso Mamburu (2016), and Khanyisa Chawane (2018).

Rademan shot 176 goals from 214 attempts for a goal average of 82%. In both the Premier League and National Championship, she received the prize for the best shooter this year.

The news comes shortly after the announcement that a UFS teammate has secured a contract to play overseas next year. Khanyisa Chawane, who impressed immensely as a member of the Proteas at this year’s World Cup, will represent Bath in Europe’s Superleague. The 23-year-old Chawane also received an offer to play in the Australian league, but the one in England suited her better.

She will return to Bloemfontein midway through the year and will still be available for the Kovsie netball team, as she will continue her studies. The talented mid-courter follows in the footsteps of Pretorius, who also spent a season with Bath in 2016.

“I am really thrilled to have signed with Bath. There is no doubt that I’m going to come out a better player; I’m grateful to have been scouted and given this opportunity to play for such a big team. It still brings tears to my eyes when I think about it.”

“My goal has always been to play abroad and to challenge myself. I always strive to better myself and give my best on and off court,” Chawane said about the opportunity next year.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept